Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Imophoron
company
About
Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- £4M
- Industries
- Biotechnology,Life Science,Therapeutics
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£4M
Imophoron has raised a total of
£4M
in funding over 2 rounds. Their latest funding was raised on
Oct 7, 2021 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 7, 2021 | Seed | £4M | 1 |
Octopus Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Imophoron is funded by 1 investors.
Octopus Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Octopus Ventures
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
